ID   CHP-100S
AC   CVCL_IV95
SY   CHP-100-S; CHP100S; CHP-100 Small
DR   Wikidata; Q54813262
RX   PubMed=6825097;
CC   Problematic cell line: Misclassified. Parent cell line (CHP-100) was originally thought to originate from a neuroblastoma but was later shown to be from an Ewing sarcoma.
CC   Doubling time: 26 hours (PubMed=6825097).
CC   Sequence variation: Gene fusion; HGNC; 3508; EWSR1 + HGNC; 3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (from parent cell line).
CC   Derived from site: In situ; Bone, spine, epidural space; UBERON=UBERON_0003691.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7166 ! CHP-100
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
RX   PubMed=6825097;
RA   Bernal S.D., Thompson R., Gilbert F., Baylin S.B.;
RT   "In vitro and in vivo growth characteristics of two different cell
RT   populations in an established line of human neuroblastoma.";
RL   Cancer Res. 43:1256-1260(1983).
//